Medtronic to acquire Covidien for $42.9 billion in cash and stock
MLex Summary: Medical device company Medtronic has agreed to acquire fellow NYSE-listed rival Covidien for $42.9 billion in a cash-and-stock transaction. The deal is expected to close in the fourth quarter of 2014 or early...To view the full article, register now.
Already a subscriber? Click here to view full article